Ares Management Gains as Investors Digest Strong Q2 Fundraising and Asset Growth

Ares Management Corporation (ARES) is up 4.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued positive reaction to Ares’ second-quarter results and filing updates, which highlighted record fundraising, rising fee-paying assets and a large pool of undeployed capital. This could also reflect investor optimism that stronger inflows and a larger investment pipeline will support future fee growth as private credit activity improves.

Details:

Ares reported second-quarter 2026 results on July 31, showing more than $36 billion of inflows in what management described as another record fundraising quarter.

Total assets under management reached about $671.3 billion at June 30, 2026, while fee-paying AUM rose to about $409.9 billion, both up 17% from a year earlier.

Available capital climbed to about $170 billion, giving the firm substantial dry powder to deploy across credit, real assets, secondaries and private equity strategies.

Management also pointed to a meaningful pickup in the firmwide investment pipeline, which may have encouraged investors looking for stronger deployment and earnings momentum ahead.

Sources:

Ares Management, U.S. Securities and Exchange Commission, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ARES Insider Trading Activity

$ARES insiders have traded $ARES stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ARES stock by insiders over the last 6 months:

JUDY D. OLIAN purchased 480 shares for an estimated $59,726

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$ARES Hedge Fund Activity

We have seen 436 institutional investors add shares of $ARES stock to their portfolio, and 432 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC removed 6,772,244 shares (-83.2%) from their portfolio in Q1 2026, for an estimated $738,851,820
WELLINGTON MANAGEMENT GROUP LLP added 5,333,577 shares (+91.5%) to their portfolio in Q1 2026, for an estimated $581,893,250
CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 4,648,323 shares (+353.5%) to their portfolio in Q1 2026, for an estimated $507,132,039
PRICE T ROWE ASSOCIATES INC /MD/ removed 3,911,335 shares (-65.3%) from their portfolio in Q1 2026, for an estimated $426,726,648
CANADA PENSION PLAN INVESTMENT BOARD added 3,138,008 shares (+70.1%) to their portfolio in Q1 2026, for an estimated $342,356,672
WINSLOW CAPITAL MANAGEMENT, LLC removed 1,911,513 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $208,546,068
NUVEEN, LLC removed 1,872,820 shares (-77.4%) from their portfolio in Q2 2026, for an estimated $208,463,594

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ARES Congressional Stock Trading

Members of Congress have traded $ARES stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ARES stock by members of Congress over the last 6 months:

SENATOR JOHN BOOZMAN purchased up to $15,000 on 03/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$ARES Price Targets

Multiple analysts have issued price targets for $ARES recently. We have seen 10 analysts offer price targets for $ARES in the last 6 months, with a median target of $149.5.

Here are some recent targets:

Devin Ryan from Citizens set a target price of $160.0 on 07/09/2026
Benjamin Budish from Barclays set a target price of $139.0 on 07/09/2026
Bill Katz from TD Cowen set a target price of $153.0 on 06/23/2026
Chris Kotowski from Oppenheimer set a target price of $146.0 on 05/04/2026
Kenneth Worthington from JP Morgan set a target price of $144.0 on 04/28/2026
Michael Cyprys from Morgan Stanley set a target price of $163.0 on 04/21/2026
Alexander Blostein from Goldman Sachs set a target price of $131.0 on 04/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.